Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report

BACKGROUND: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Weingarten, Sarah J., Friedman, Deborah, Arora, Anubha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788087/
https://www.ncbi.nlm.nih.gov/pubmed/33437657
http://dx.doi.org/10.1016/j.crwh.2020.e00281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788087/
https://www.ncbi.nlm.nih.gov/pubmed/33437657
http://dx.doi.org/10.1016/j.crwh.2020.e00281

Ejemplares similares